Search Results - "Ishioka, GY"

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide by Tangri, S, Ishioka, G Y, Huang, X, Sidney, J, Southwood, S, Fikes, J, Sette, A

“…Certain peptide analogs that carry substitutions at residues other than the main major histocompatibility complex anchors and are surprisingly much more…”
Get full text

Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes by Ishioka, Glenn Y, Fikes, John, Hermanson, Gary, Livingston, Brian, Crimi, Claire, Qin, Mingsheng, France del Guercio, Marie, Oseroff, Carla, Dahlberg, Carol, Alexander, Jeff, Chesnut, Robert W, Sette, Alessandro

“…We engineered a multiepitope DNA minigene encoding nine dominant HLA-A2.1- and A11-restricted epitopes from the polymerase, envelope, and core proteins of…”
Get full text

MHC interaction and T cell recognition of carbohydrates and glycopeptides by Ishioka, GY, Lamont, AG, Thomson, D, Bulbow, N, Gaeta, FC, Sette, A, Grey, HM

“…The T cell independence of complex polysaccharide Ag has suggested the possibility that carbohydrates may be incapable of T cell recognition because of a…”
Get full text

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis by Franco, A, Southwood, S, Arrhenius, T, Kuchroo, V K, Grey, H M, Sette, A, Ishioka, G Y

“…The feasibility of using T cell receptor (TcR) antagonist peptides to inhibit autoimmune disease has been examined. First, the fine antigenic structure of the…”
Get more information

Lipopeptide particles as the immunologically active component of CTL inducing vaccines by Tsunoda, Ikuo, Sette, Alessandro, Fujinami, Robert S., Oseroff, Carla, Ruppert, Jorg, Dahlberg, Carol, Southwood, Scott, Arrhenius, Thomas, Kuang, Li-Qing, Kubo, Ralph T., Chesnut, Robert W., Ishioka, Glenn Y.

“…Using a bipalmitoylated lipopeptide consisting of an ovalbumin helper T-cell epitope covalently linked to an influenza virus cytotoxic T-lymphocyte (CTL)…”
Get full text

cDNA cloning and immunological characterization of the rye grass allergen Lol p I by Perez, M, Ishioka, G Y, Walker, L E, Chesnut, R W

“…The complete amino acid sequence of two “isoallergenic” forms of Lol p I, the major rye grass (Lolium perenne) pollen allergen, was deduced from cDNA sequence…”
Get full text

Recognition of T cell epitopes and lymphokine secretion by rye grass allergen Lolium perenne I-specific human T cell clones by Spiegelberg, HL, Beck, L, Stevenson, DD, Ishioka, GY

“…T cell lines (TCL) and CD4+ T cell clones (TCC) with specificity for the rye grass allergen Lolium perenne (Lol p) I were isolated from the blood of nine…”
Get full text

Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function by Ishioka, Glenn Y, Fikes, John, Qin, Mingsheng, Gianfrani, Carmen, Chesnut, Robert W, Kahn, Larry E, Streeter, Philip R, Woulfe, Susan L, Sette, Alessandro

“…Recently, a dual receptor agonist for human Flt3 and G-CSF receptors, progenipoietin-4 (ProGP-4), was shown to be highly effective in expanding DC in vivo. In…”
Get full text

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides by Ishioka, GY, Adorini, L, Guery, JC, Gaeta, FC, LaFond, R, Alexander, J, Powell, MF, Sette, A, Grey, HM

“…Peptides that bind with high affinity to class II MHC molecules can inhibit T cell activation both in vitro and in vivo. Thus, they have been suggested as…”
Get full text

Definition of a DQ3.1-specific binding motif by Sidney, J, Oseroff, C, del Guercio, MF, Southwood, S, Krieger, JI, Ishioka, GY, Sakaguchi, K, Appella, E, Sette, A

“…A quantitative peptide binding assay using purified DQA1*0301/DQB1*0301 (DQ3.1) molecules was developed and validated by examining the correlation between the…”
Get full text

Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo by Ishioka, GY, Colon, S, Miles, C, Grey, HM, Chesnut, RW

“…The present study investigated the possibility that protein Ag fragments in the form of peptides could serve as the priming Ag in the generation of a MHC class…”
Get full text

Antigen analogs as therapeutic agents by Alexander, J, Ruppert, J, Page, D M, Hedrick, S M, Franco, A, Ishioka, G Y, Grey, H M, Sette, A

Get more information

Studies on the capacity of B cells as well as T cells to serve as accessory cells for the activation of herpes simplex virus-specific cytolytic T cells by Grammer, SF, Ishioka, GY, Chesnut, RW

“…Experiments were conducted in an effort to determine the ability of B and T lymphocytes to serve as APC for the activation of HSV-primed splenic T cells to…”
Get full text

Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells by Schrier, RD, Ishioka, GY, Pizer, LI, Moorhead, JW

“…We have been studying delayed hypersensitivity (DH) to herpes simplex virus (HSV) in order to examine the role of this response in host defense against acute…”
Get full text

Major histocompatibility complex class II association and induction of T cell responses by carbohydrates and glycopeptides by Ishioka, G Y, Lamont, A G, Thomson, D, Bulbow, N, Gaeta, F C, Sette, A, Grey, H M

Get more information

MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression? by Ruppert, J, Franco, A, Alexander, J, Snoke, K, Ishioka, G Y, Page, D M, Hedrick, S M, Adorini, L, Grey, H M, Sette, A

Get more information

Anticancer activity of narcissus extracts in mice by Furusawa, E, Suzuki, N, Tani, S, Furusawa, S, Ishioka, G Y, Motobu, J

Get more information